B Group, Inc. Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$116.7B
Holdings
19
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (19 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ADMAADMA BIOLOGICS INC | 2,317,542 | $46.0B | 39.39% | |
| 2 | IM8NINSMED INC | 262,500 | $20.0B | 17.16% | |
| 3 | ZLABZAI LAB LTD | 400,000 | $14.5B | 12.38% | |
| 4 | AKROAKERO THERAPEUTICS INC | 242,500 | $9.8B | 8.41% | |
| 5 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,500,000 | $5.0B | 4.28% | |
| 6 | CLLSCELLECTIS S A | 3,256,501 | $4.0B | 3.46% | |
| 7 | AURAAURA BIOSCIENCES INC | 472,576 | $2.8B | 2.37% | |
| 8 | SGHTSIGHT SCIENCES INC | 833,600 | $2.0B | 1.71% | |
| 9 | ASMBASSEMBLY BIOSCIENCES INC | 200,000 | $1.9B | 1.64% | |
| 10 | TSHATAYSHA GENE THERAPIES INC | 1,255,556 | $1.7B | 1.50% | |
| 11 | RAREULTRAGENYX PHARMACEUTICAL IN | 47,500 | $1.7B | 1.47% | |
| 12 | BNTXBIONTECH SE | 15,000 | $1.4B | 1.17% | |
| 13 | RAREULTRAGENYX PHARMACEUTICAL IN | 37,600 | $1.4B | 1.17% | Call |
| 14 | SYRESPYRE THERAPEUTICS INC | 70,000 | $1.1B | 0.97% | |
| 15 | APGEAPOGEE THERAPEUTICS INC | 30,000 | $1.1B | 0.96% | |
| 16 | PRAXPRAXIS PRECISION MEDICINES I | 19,000 | $719.5M | 0.62% | |
| 17 | ETNBGBP89BIO INC | 95,623 | $695.2M | 0.60% | |
| 18 | ORKAORUKA THERAPEUTICS INC | 58,215 | $597.3M | 0.51% | |
| 19 | CRVSCORVUS PHARMACEUTICALS INC | 90,000 | $286.2M | 0.25% | Put |